Oregon Cancer

News and information for cancer services throughout Oregon.

  • How cold cap therapy prevented patient’s hair loss during cancer treatment

    How cold cap therapy prevented patient’s hair loss during cancer treatment

    What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.

    Read Article
  • New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

    New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

    Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

    Read Article
  • Providence researchers share cancer discoveries at 2025 ASCO meeting

    Providence researchers share cancer discoveries at 2025 ASCO meeting

    Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.

    Read Article
  • Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

    Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

    Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.

    Read Article
  • Studies to be presented by Providence researchers at AACR annual meeting

    Studies to be presented by Providence researchers at AACR annual meeting

    The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

    Read Article
  • Seeking better treatments for people with ER+/HER- breast cancer

    Seeking better treatments for people with ER+/HER- breast cancer

    Two studies for people with ER+/HER2- breast cancer are enrolling patients at Providence Cancer Institute.

    Read Article
  • From life-saving surgery to back on the slopes: A photographer’s story

    From life-saving surgery to back on the slopes: A photographer’s story

    Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.

    Read Article
  • Robotic versus open surgery for early cervical cancer

    Robotic versus open surgery for early cervical cancer

    This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.

    Read Article
  • A year to remember: Advancements, recognition and transitions

    A year to remember: Advancements, recognition and transitions

    Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

    Read Article
  • CAR T cell-therapy, hope and healing: Dean’s story

    CAR T cell-therapy, hope and healing: Dean’s story

    Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.

    Read Article
  • Two clinical trials for solid tumor cancers take different approaches to stop growth

    Two clinical trials for solid tumor cancers take different approaches to stop growth

    Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.

    Read Article
  • Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

    Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

    Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

    Read Article
  • Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains

    Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains

    R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

    Read Article
  • 2024 SITC Meeting: A glimpse of recent advancements in immunotherapy

    2024 SITC Meeting: A glimpse of recent advancements in immunotherapy

    The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.

    Read Article
  • Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

    Read Article
  • New studies test immunotherapy to boost breast cancer treatment and prevent return

    New studies test immunotherapy to boost breast cancer treatment and prevent return

    Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

    Read Article
  • Attend a free virtual symposium on melanoma, Oct. 25

    Attend a free virtual symposium on melanoma, Oct. 25

    Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

    Read Article
  • Prostate cancer study includes a tumor test to personalize treatment

    Prostate cancer study includes a tumor test to personalize treatment

    A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

    Read Article
  • Meet physician scientist, Dr. Allie Grossmann

    Meet physician scientist, Dr. Allie Grossmann

    Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.

    Read Article
  • Dr. Walter Urba announces retirement from Providence

    Dr. Walter Urba announces retirement from Providence

    Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

    Read Article
  • loading
    Loading More...